Home > Homocysteine status modifies the treatment effect of omega-3 fatty acids on cognition in a randomized clinical trial in mild to moderate Alzheimer’s disease: The OmegAD study
Homocysteine status modifies the treatment effect of omega-3 fatty acids on cognition in a randomized clinical trial in mild to moderate Alzheimer’s disease: The OmegAD study
Manuscript Number:
18-1148R2
Author(s):
Hans Basun, Tommy Cederholm, Maria Eriksdotter, Gerd Faxen-Irving, Yvonne Freund-Levi, Erik Hjorth, Fredrik Jernerén, Jan Palmblad, Helga Refsum, Marianne Schultzberg, A. David Smith, Cheryl Turner, Lars-Olof Wahlund
